Singapore Biotech Pte. Ltd.
Exhibitor at CPhI Worldwide 2019 stand 90B90, Finished Dosage Formulations
Singapore Biotech is a trusted Biologic company that changes lives by making advanced biologics more accessible and more affordable.
The EU-GMP certified manufacturing facilities enable us to deliver world-class quality biosimilars to patients, across the globe.
Utilizing latest manufacturing technologies is our competitive edge to support our international partners to increase uptake of biosimilars in different regions.
Business Model and Partnering Structures at Singapore Biotech:
· Out licensing
· Supply and Distribution (API and Finished Product)
· Technology Transfer
· Contract Manufacturing
Our Target Therapeutic Areas:
· Neurology (Interferon beta-1a)
· Oncology & Hematology (Erythropoietin beta, Pegylated filgrastim, Rituximab, Trastuzumab, Bevacizumab and rFactor VII)
· Gynecology & Endocrinology (Follitropin alfa and Somatropin)
· Rheumatology (Teriparatide, Adalimumab and Etanercept)
Specs about this supplier
|Affiliated categories:||Antibodies |Biomanufacturing |Biopharmaceuticals (general category) More|
Products featured at CPhI Worldwide 2019
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation